![](images/graphics/blank.gif)
Giant Cell Tumor of bone
-
We report on a patient who presented to the ear, nose, and throat (ENT) clinic with an 8-month-old left non-pulsatile tinnitus. Imaging studies, Neck computed tomography (CT) and magnetic resonance imaging (MRI) revealed soft tissue mass in the left middle ear with invasion to the middle cranial fossa and external auditory canal.
3p
viintuit
26-09-2023
0
0
Download
-
Giant cell tumor of bone (GCTB) is a rare osteoclastogenic stromal tumor. GCTB can rarely undergo malignant transformation. This post hoc analysis evaluated and classified malignancies in patients with GCTB who received denosumab.
12p
vianrose2711
27-04-2021
6
0
Download
-
Aggressive curettage has been well established for the treatment of giant cell tumors (GCTs) of the bone. The purpose of this study was to review our experience and evaluate the role of different implant materials in patients with GCTs of the extremities after aggressive curettage.
8p
viannito2711
20-04-2021
10
2
Download
-
Giant cell tumors (GCT) around the knee are common and pose a special problem of reconstruction after tumor excision, especially for grade III GCT. We questioned whether en bloc resection and reconstruction with alcohol inactivated autograft-prosthesis composite would provide (1) local control and long-term survival and (2) useful limb function in patients who had grade III GCT around the knee.
7p
vianrose2711
26-04-2021
9
2
Download
-
Giant cell tumor of bone is a benign, locally aggressive neoplasm. Surgical resection is the preferred treatment method. However, for cases in which resection poses an increased risk to the patient, denosumab (antiRANKL monoclonal antibody) is considered.
7p
vianttinic2711
20-04-2021
9
2
Download
-
Giant cell tumor of the bone (GCTB) is classified as an intermediate, locally aggressive but rarely metastasizing tumor. The mainstay of treatment for the treatment of GCTB had been the surgical removal until an anti- receptor activator of nuclear factor-kappa B ligands (RANKL) antibody denosumab was developed.
7p
vioregon2711
22-02-2021
8
1
Download
-
Pigmented villonodular synovitis (PVNS) is an uncommon entity of proliferative lesion of the synovium, presenting with different clinical signs and symptoms. PVNS rarely forms an osteolytic lesion in a bone. Here we report a unique case of PVNS with a nodular lesion in the left patella.
7p
vitennessee2711
02-02-2021
7
1
Download
-
Diffused-type giant cell tumor(Dt-GCT) is a rare, aggressive disorder of the joint synovium, bursa and tendon sheaths. Osseous erosions and subchondral cysts may develop as the result of synovium infiltration in DtGCT.
7p
vitennessee2711
02-02-2021
11
2
Download
-
In 2013, denosumab was introduced as peri-operative adjuvant treatment for giant cell tumor (GCT) of bone as it inhibits osteoclast activity. It is suggested that denosumab relives pain, facilitate curettage in lesions requiring resection initially.
9p
vimariana2711
22-12-2020
7
1
Download
-
Multiple primary tumors, especially quadruple primary neoplasms is extremely rare. Fibrous dysplasia (FD), osteosarcoma (OS), and giant cell tumor of bone (GCTB) are three bone tumors with low incidence while primary pulmonary meningioma is a rare disease. In this case report, we present a unique synchronous occurrence of these four separate pathological conditions.
8p
vimariana2711
22-12-2020
13
0
Download
-
Growing evidence exists that the neoplastic stromal cell population (GCTSC) within giant cell tumors (GCT) originates from mesenchymal stem cells (MSC). In a previous study we identified a microRNA signature that differentiates between these cell types.
10p
virose2711
22-09-2020
11
2
Download
-
The aim of this study is to present and evaluate surgical resection and reconstructive techniques using autologous femoral head bone-grafting in treating partial acetabular defects arising from primary pelvic malignant tumors.
9p
vikuala271
13-06-2020
4
0
Download
-
Aneurysmal bone cyst (ABC) secondary to Giant Cell Tumor of bone (GCT) is a rare lesion, of which the incidence is about 0.011 to 0.053 per 100,000 every year. There are only a few previous case reports, and most of them occur in the spine, long bones or flat bones.
6p
vijakarta2711
09-06-2020
9
1
Download
-
(bq) part 2 book "pathology of the maxillofacial bones - a guide to diagnosis" presentation of content: fibro-osseous lesions, giant cell lesions, bone tumors, other lesions involving the maxillofacial skeleton, diseases of the temporomandibular joint.
131p
thangnamvoiva23
06-10-2016
30
3
Download
-
Tham khảo tài liệu 'báo cáo hóa học:" role of the vegf-flt-1-fak pathway in the pathogenesis of osteoclastic bone destruction of giant cell tumors of bone"', luận văn - báo cáo phục vụ nhu cầu học tập, nghiên cứu và làm việc hiệu quả
8p
sting01
15-01-2012
85
5
Download
-
Tuyển tập các báo cáo nghiên cứu về hóa học được đăng trên tạp chí sinh học quốc tế đề tài : Role of the VEGF-Flt-1-FAK pathway in the pathogenesis of osteoclastic bone destruction of giant cell tumors of bone
8p
panasonic10
14-01-2012
42
2
Download
CHỦ ĐỀ BẠN MUỐN TÌM
![](images/graphics/blank.gif)